# Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia

> **NCT01849237** · PHASE1,PHASE2 · UNKNOWN · sponsor: **National Research Center for Hematology, Russia** · enrollment: 30 (estimated)

## Conditions studied

- Septic Shock
- Nonchemotherapy Drug-induced Neutropenia
- Neutropenia After Chemotherapy in Oncohematological Patients
- Neutropenia in Patients With Aplastic Anemia

## Interventions

- **GENETIC:** Mesenchymal stromal cells
- **DRUG:** Standard therapy of septic shock

## Key facts

- **NCT ID:** NCT01849237
- **Lead sponsor:** National Research Center for Hematology, Russia
- **Sponsor class:** NETWORK
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2013-04
- **Final completion:** 2015-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01849237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01849237, "Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01849237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*